PURLs: Counseling is a must with this smoking cessation aid
- PMID: 22393555
- PMCID: PMC3297364
PURLs: Counseling is a must with this smoking cessation aid
Abstract
For many smokers, the benefits of quitting will outweigh the risks associated with varenicline.
Comment in
-
Newer study shows smoking cessation aid is safe.J Fam Pract. 2013 Apr;62(4):174. J Fam Pract. 2013. PMID: 23687680 No abstract available.
Comment on
-
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.CMAJ. 2011 Sep 6;183(12):1359-66. doi: 10.1503/cmaj.110218. Epub 2011 Jul 4. CMAJ. 2011. PMID: 21727225 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity Losses-United States, 2000-2004. MMWR Morbidity and Mortality Weekly Report. 2008;57:1226–1228.. - PubMed
-
- Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease. JAMA. 2003;290:86–97.. - PubMed
-
- US Preventive Services Task Force. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women. Ann Intern Med. 2009;150: 551–555.. - PubMed
-
- US Food and Drug Administration. Boxed warning on serious mental health events to be required for Chantix and Zyban [press release]. July 1, 2009. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm170100.htm#.... Accessed January 21, 2012.